Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular Surgery

NCT04703582 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-01-11

No results posted yet for this study

Summary

Check whether patients with higher comorbidity and risk of complication, estimated using the V (p) -POSSUM score, ACS NSQIP and the ASA classification, present higher baseline activated clotting time values.

Conditions

  • Artery Disease, Peripheral
  • Aortic Diseases
  • Carotid Artery Diseases
  • Other Disease

Interventions

DIAGNOSTIC_TEST

Activated clotting time

Relationship between elongated baseline activated clotting time and comorbidity

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2021-03-31
Completion
2021-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04703582 on ClinicalTrials.gov